Headline
The latest stories from AHA Today.
The Biden administration today provided details on its plan to allocate 25 million COVID-19 vaccine doses to low- and middle-income nations.
Leaders from Chicago-based Esperanza Health Centers, a federally qualified health center, discuss their work to keep the city’s Southwest Side community healthy throughout the COVID-19 pandemic.
Our hospitals and health systems are not immune to violence, but they have made great efforts to curb it, writes AHA Board member and Hospitals Against Violence advisory group chair Mary Beth Kingston, R.N.
The Government Accountability Office this week appointed two new members to the Medicare Payment Advisory Commission and reappointed four current members.
AHA encourages hospitals, health systems, community organizations, public health departments and other partners to participate by using #CHIWeek on social media to share stories, events and ways to promote health and reducing health inequities.
AHA’s Hospitals Against Violence gathered more than 217 health care professionals and community partners to hear from human trafficking experts, survivors and health care leaders who are working to advance anti-trafficking efforts in their organizations.
The National Institutes of Health yesterday reported that a healthy diet from around the time of conception through the second trimester may reduce for women the risk of several common pregnancy complications.
On June 4, AHA’s Hospitals Against Violence initiative encourages everyone to stand together for the fifth-annual #HAVhope Friday. This national day of awareness unites hospitals, health systems, nurses, doctors and other professionals to highlight programs and initiatives that help mitigate…
New research by the National Institutes of Health has confirmed the safety of blood donation and transfusions from COVID-19. NIH concluded that transfusions’ likelihood of infection transmission is a little over 1 in 100,000, or 0.001%.
Moderna yesterday announced an agreement to use Thermo Fisher Scientific to increase the scale of its COVID-19 vaccine finish/fill sterile manufacturing. The deal will enable production to begin in the third quarter of 2021.